Evidence map›Paper›PMID 36780539›Full record

ArticlePloS one2023

Treatment of tubular damage in high-fat-diet-fed obese mice using sodium-glucose co-transporter inhibitors.

Sei Saitoh, Takashi Takaki, Kazuki Nakajima, Bao Wo, Hiroshi Terashima, Satoshi Shimo, Huy Bang Nguyen, Truc Quynh Thai, Kanako Kumamoto, Kazuo Kunisawa and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

Sei SaitohDepartment of Biomedical Molecular Sciences (Anatomy II), Fujita Health University School of Medicine, Toyoake, Japan.ORCID 0000-0001-6072-4287
Takashi TakakiDepartment of Anatomy, Showa University School of Medicine, Tokyo, Japan.
Kazuki NakajimaCenter for Joint Research Facilities Support, Research Promotion and Support Headquarters, Fujita Health University, Toyoake, Japan.
Bao WoDepartment of Anatomy and Molecular Histology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Chuo, Japan.
Hiroshi TerashimaJEOL Ltd., Akishima, Japan.
Satoshi ShimoDepartment of Occupational Therapy, Health Science University, Fujikawaguchiko, Japan.
Huy Bang NguyenDivision of Neurobiology and Bioinformatics, National Institute for Physiological Sciences, Okazaki, Japan.
Truc Quynh ThaiDivision of Neurobiology and Bioinformatics, National Institute for Physiological Sciences, Okazaki, Japan.
Kanako KumamotoEducation and Research Facility of Animal Models for Human Diseases, Fujita Health University, Toyoake, Japan.
Kazuo KunisawaDepartment of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan.
Shizuko NagaoEducation and Research Facility of Animal Models for Human Diseases, Fujita Health University, Toyoake, Japan.
Akihiro TojoDivision of Nephrology & Hypertension, Dokkyo Medical University, Mibu, Japan.
Nobuhiko OhnoDivision of Ultrastructural Research, National Institute of Physiological Sciences, Okazaki, Japan.
Kazuo TakahashiDepartment of Biomedical Molecular Sciences (Anatomy II), Fujita Health University School of Medicine, Toyoake, Japan.
Fujita Health University · JPChifeng University · CNDokkyo Medical University · JPJEOL (Japan) · JPJichi Medical University · JPPham Ngoc Thach University of Medicine · VNShowa University · JPUniversity of Medicine and Pharmacy at Ho Chi Minh City · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A long-term high-fat diet (HFD) causes obesity and changes in renal lipid metabolism and lysosomal dysfunction in mice, causing renal damage. Sodium-glucose co-transporter inhibitors, including phlorizin, exert nephroprotective effects in patients with chronic kidney disease, but the underlying mechanism remains unclear. A HFD or standard diet was fed to adult C57BL/6J male mice, and phlorizin was administered. Lamellar body components of the proximal tubular epithelial cells (PTECs) were investigated. After phlorizin administration in HFD-fed mice, sphingomyelin and ceramide in urine and tissues were assessed and label-free quantitative proteomics was performed using kidney tissue samples. Mitochondrial elongation by fusion was effective in the PTECs of HFD-fed obese mice under phlorizin administration, and many lamellar bodies were found in the apical portion of the S2 segment of the proximal tubule. Phlorizin functioned as a diuretic, releasing lamellar bodies from the apical membrane of PTECs and clearing the obstruction in nephrons. The main component of the lamellar bodies was sphingomyelin. On the first day of phlorizin administration in HFD-fed obese mice, the diuretic effect was increased, and more sphingomyelin was excreted through urine than in vehicle-treated mice. The expressions of three peroxisomal β-oxidation proteins involved in fatty acid metabolism were downregulated after phlorizin administration in the kidneys of HFD-fed mice. Fatty acid elongation protein levels increased with phlorizin administration, indicating an increase in long-chain fatty acids. Lamellar bodies accumulated in the proximal renal tubule of the S2 segment of the HFD-fed mice, indicating that the urinary excretion of lamellar bodies has nephroprotective effects.

Indexed as

Diet, High-FatSymportersAnimalsFatty AcidsGlucoseMaleMiceMice, Inbred C57BLMice, ObesePhlorhizinSodiumSphingomyelinsFatty AcidsGlucosePhlorhizinSodiumSphingomyelinsSymporters

Identifiers

PMID36780539
PMCPMC9925073
OpenAlexW4320483700

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.